CAEX
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
08/07/2026
Back to search
Official data from USPTO
VERNALIS
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9Type: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Case type
Application and registration
Recorded events
42
Latest update
08/07/2026
Trademark type
Word
Nice classes
5, 42
Filing date
04/08/2015
Registration date
01/26/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/07/2026
Last transaction
08/07/2026
Responsible office
United States Patent and Trademark Office
Status code
710
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
11
Owner location
CAMBRIDGE, GB
Examiner
STRINGER, DANIEL
Law office
L30
Holders and representatives
Holders
VERNALIS (R&D) LIMITED
Vernalis Development Limited
Vernalis Development Limited
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterialviral or fungal agent in skin infectionsinfections of major organsearnose and throat infectionsrespiratory infectionssubcutaneous infectionsblood infectionscerebral infections and sexually transmitted infectionsneurological and psychological disordersnervous system diseases and disordersmigrainesheadachescoughscoldsallergies and respiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsorgan damagecell proliferationblood disorderspaincancerswomen's health issues in the nature of medical conditions relating to reproduction disordersconception disorderspregnancy and contraception disordersmenstrual disorderspost-menopausal disorderssexual function disordersfemale hormone disordersosteoporosis and breast canceruterine and ovarian cancermen's health issues in the nature of reproduction disordersconception disorderscontraception disordersprostate disorderstestes disordersmale hormone disordersalopeciasexual function disordersprostate cancertesticular cancer and impotenceendocrinology disorderspediatrics issues in the nature of mental health disordersdiabetes and endocrinology disordersgastroenterology disordersherpetology disordersimmunology disordersskin infectionsallergiesnephology disordersneurodisability disordersneurology disordersoncology disordersrespiratory disordersrheumatology disordersdermatology disorderscardiology disordersgeriatrics issues in the nature of clinicalpreventativeremedial and social aspects of illness in the elderly in the nature of immobility disordersincontinence disordersmental health disordersstrokesheart diseaseinfectious diseasesdiabetesdeliriumsyncopecerebral aging and Parkinsonisminflammation disorders; Sanitary preparations for medical purposes; Dietetic food and substances for medical or veterinary use in the nature of pastabreadscerealscrackersmeatfruitvegetablesconfectionerylipids in the nature of margarinebutter substitutelardfish oilbutterpeanut oilsoya bean oilsunflower oilsesame oilcoconut oilolive oilanimal-derived fats and oilsplant-derived oils and dairy products in the nature of cheesemilkbutteryoghurtcreamcurdsall adapted for medical use; dietary supplements for humans and animals; chemical reagents for medical or veterinary purposes; chemical medical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for the treatment and prophylaxis of infections by a bacterialviral or fungal agent in skin infectionsinfections of major organsearnose and throat infectionsrespiratory infectionssubcutaneous infectionsblood infectionscerebral infections and sexually transmitted infectionsneurological and psychological disordersnervous system diseases and disordersmigrainesheadachescoughscoldsallergies and respiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsorgan damagecell proliferationblood disorderspaincancerswomen's health issues in the nature of medical conditions relating to reproduction disordersconception disorderspregnancy and contraception disordersmenstrual disorderspost-menopausal disorderssexual function disordersfemale hormone disordersosteoporosis and breast canceruterine and ovarian cancermen's health issues in the nature of reproduction disordersconception disorderscontraception disordersprostate disorderstestes disordersmale hormone disordersalopeciasexual function disordersprostate cancertesticular cancer and impotenceendocrinology disorderspediatrics issues in the nature of mental health disordersdiabetes and endocrinology disordersgastroenterology disordersherpetology disordersimmunology disordersskin infectionsallergiesnephology disordersneurodisability disordersneurology disordersoncology disordersrespiratory disordersrheumatology disordersdermatology disorderscardiology disordersgeriatrics issues in the nature of clinicalpreventativeremedial and social aspects of illness in the elderly in the nature of immobility disordersincontinence disordersmental health disordersstrokesheart diseaseinfectious diseasesdiabetesdeliriumsyncopecerebral aging and Parkinsonisminflammation disorders; medical chemical preparations for the treatment and prophylaxis of infections by a bacterialviral or fungal agent in skin infectionsinfections of major organsearnose and throat infectionsrespiratory infectionssubcutaneous infectionsblood infectionscerebral infections and sexually transmitted infectionsneurological and psychological disordersnervous system diseases and disordersmigrainesheadachescoughscoldsallergies and respiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsorgan damagecell proliferationblood disorderspaincancerswomen's health issues in the nature of medical conditions relating to reproduction disordersconception disorderspregnancy and contraception disordersmenstrual disorderspost-menopausal disorderssexual function disordersfemale hormone disordersosteoporosis and breast canceruterine and ovarian cancermen's health issues in the nature of reproduction disordersconception disorderscontraception disordersprostate disorderstestes disordersmale hormone disordersalopeciasexual function disordersprostate cancertesticular cancer and impotenceendocrinology disorderspediatrics issues in the nature of mental health disordersdiabetes and endocrinology disordersgastroenterology disordersherpetology disordersimmunology disordersskin infectionsallergiesnephology disordersneurodisability disordersneurology disordersoncology disordersrespiratory disordersrheumatology disordersdermatology disorderscardiology disordersgeriatrics issues in the nature of clinicalpreventativeremedial and social aspects of illness in the elderly in the nature of immobility disordersincontinence disordersmental health disordersstrokesheart diseaseinfectious diseasesdiabetesdeliriumsyncopecerebral aging and Parkinsonisminflammation disorders; medicines for the treatment and prophylaxis of infections by a bacterialviral or fungal agent in skin infectionsinfections of major organsearnose and throat infectionsrespiratory infectionssubcutaneous infectionsblood infectionscerebral infections and sexually transmitted infectionsneurological and psychological disordersnervous system diseases and disordersmigrainesheadachescoughscoldsallergies and respiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsorgan damagecell proliferationblood disorderspaincancerswomen's health issues in the nature of medical conditions relating to reproduction disordersconception disorderspregnancy and contraception disordersmenstrual disorderspost-menopausal disorderssexual function disordersfemale hormone disordersosteoporosis and breast canceruterine and ovarian cancermen's health issues in the nature of reproduction disordersconception disorderscontraception disordersprostate disorderstestes disordersmale hormone disordersalopeciasexual function disordersprostate cancertesticular cancer and impotenceendocrinology disorderspediatrics issues in the nature of mental health disordersdiabetes and endocrinology disordersgastroenterology disordersherpetology disordersimmunology disordersskin infectionsallergiesnephology disordersneurodisability disordersneurology disordersoncology disordersrespiratory disordersrheumatology disordersdermatology disorderscardiology disordersgeriatrics issues in the nature of clinicalpreventativeremedial and social aspects of illness in the elderly in the nature of immobility disordersincontinence disordersmental health disordersstrokesheart diseaseinfectious diseasesdiabetesdeliriumsyncopecerebral aging and Parkinsonisminflammation disorders
Class 42
Scientific and technological servicespharmaceutical product evaluationdevelopment and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluationdevelopment and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluationdevelopment and testing services; scientificmedical and clinical research and development in the nature of pharmaceutical product evaluationdevelopment and testing services; research and development in the nature of pharmaceutical product evaluationdevelopment and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluationdevelopment and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product evaluationdevelopment and testing services; conducting product evaluations in the field of new pharmaceuticals; inspection of pharmaceuticals; pharmaceutical product evaluation; pharmaceutical drug development services
Publications
History of USPTO decisions and trademark events.
42 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/26/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/10/2022
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/10/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/10/2022
E815
TEAS SECTION 8 & 15 RECEIVED
12/21/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/16/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/16/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/16/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/30/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/16/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/19/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/19/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/19/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/19/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/19/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2015
PUBO
PUBLISHED FOR OPPOSITION
11/10/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/05/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
10/01/2015
ALIE
ASSIGNED TO LIE
10/01/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/01/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
10/01/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/01/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/25/2015
GNRT
NON-FINAL ACTION E-MAILED
09/25/2015
CNRT
NON-FINAL ACTION WRITTEN
09/25/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/23/2015
GNRT
NON-FINAL ACTION E-MAILED
07/23/2015
CNRT
NON-FINAL ACTION WRITTEN
07/23/2015
DOCK
ASSIGNED TO EXAMINER
07/15/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2015
NWAP
NEW APPLICATION ENTERED
04/11/2015
Continuous trademark protection
Get notified about every new filing that threatens VERNALIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.